Concepedia
Statistics
Publications
3
Citations
391
H-Index
Active since
2011
Affiliations
Hebrew University of Jerusalem(Current)
Hadassah Medical Center
Tel Aviv University
Sheba Medical Center
Zivia Brunschwig is an author at Hebrew University of Jerusalem specializing in muscular dystrophy, pharmacology, and medicine.
Publications per year
2011–2013
Mutant KRAS is a druggable target for pancreatic cancer
Elina Zorde Khvalevsky, Racheli Gabai, Itzhak H. Rachmut et al. · Proceedings of the National Academy of Sciences · 2013 · 290 citations · Full text
Medicine, Molecular Biology, Oncology +17
Losartan, a therapeutic candidate in congenital muscular dystrophy: Studies in the <i>dy<sup>2J</sup>/dy<sup>2J</sup></i> Mouse
Nurit Yanay, Shlomit Aga‐Mizrachi, Zivia Brunschwig et al. · Annals of Neurology · 2011 · 79 citations
Medicine, Pharmacology, Pharmacotherapy +14
The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in dy2J/dy2J Mouse Model of Muscular Dystrophy
Yoram Nevo, Shlomit Aga‐Mizrachi, Edva Elmakayes et al. · PLoS ONE · 2011 · 22 citations · Full text
Life Sciences, Biochemistry, Pharmacology +17
1–3 of 3